FIELD: medicine.
SUBSTANCE: group of inventions concerns medicine, namely immunoprophylaxis and can be used for Neisseria meningitidis immunisation. The method under the invention provides introduction to the patient pre-immunised with diphtheritic anatoxin or its derivative, of conjugate meningococcal capsular saccharides with diphtheritic anatoxin or its derivative. Herewith the patient is pre-immunised with diphtheritic anatoxin (or its derivative). Application under the invention concerns manufacturing of a medical product for prevention of the disease caused by Neisseria meningitidis.
EFFECT: application of the inventions allows crating the immune response against Neisseria meningitidis in the diphtheria-immunised patients without immunological interference between meningococcal conjugates and diphtheria immunity.
42 cl, 5 tbl
Authors
Dates
2010-01-20—Published
2005-04-29—Filed